Evidence map›Paper›PMID 40490453›Full record

ArticleNature communications2025

Bioenergetic stress potentiates antimicrobial resistance and persistence.

Barry Li, Shivani Srivastava, Mustafa Shaikh, Gautam Mereddy, Madison R Garcia, Eric N Chiles, Avi Shah, Boatema Ofori-Anyinam, Ting-Yu Chu, Nicole J Cheney and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Barry LiCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.ORCID http://orcid.org/0000-0003-1102-561X
Shivani SrivastavaCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Mustafa ShaikhCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Gautam MereddyCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Madison R GarciaCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.ORCID http://orcid.org/0009-0009-1878-9146
Eric N ChilesRutgers Cancer Institute of New Jersey; Rutgers University, The State University of New Jersey, New Brunswick, NJ, USA.
Avi ShahCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Boatema Ofori-AnyinamCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Ting-Yu ChuCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.ORCID http://orcid.org/0009-0001-0578-3142
Nicole J CheneyCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Douglas McCloskeyNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Xiaoyang SuRutgers Cancer Institute of New Jersey; Rutgers University, The State University of New Jersey, New Brunswick, NJ, USA.ORCID http://orcid.org/0000-0001-8081-1396
Jason H YangCenter for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA. jason.y@rutgers.edu.ORCID http://orcid.org/0000-0003-0921-4657

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Systems Biology CoreU19AI162598 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI DIETZE, REYNALDO · 2021 to 2025
$13.9M
Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosisR01AI146194 · NIAID · UNIVERSITY OF WASHINGTON · PI ALLAND, DAVID, SHERMAN, DAVID R · 2020 to 2024
$4.1M
Effects of Host Metabolic Variation on Antibiotic SusceptibilityR00GM118907 · NIGMS · RBHS-NEW JERSEY MEDICAL SCHOOL · PI YANG, JASON HUNG-YING · 2020 to 2022
$747k
NCI NIH HHS P30 CA072720NIAID NIH HHS R01 AI146194NIAID NIH HHS U19 AI162598NIGMS NIH HHS R00 GM118907Novo Nordisk Fonden (Novo Nordisk Foundation) NNF10CC1016517U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30-CA072720U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-AI146194U.S. Department of Health & Human Services | National Institutes of Health (NIH) U19-AI62598
6 · The paper itself

Abstract

The bactericidal action of some antibiotics is associated with increased ATP consumption, cellular respiration, and reactive oxygen species (ROS) formation. Here, we investigate the effects of 'bioenergetic stress', induced by constitutive hydrolysis of ATP and NADH, on antibiotic efficacy in Escherichia coli. We show that bioenergetic stress potentiates the evolution of antibiotic resistance via enhanced ROS production, mutagenic break repair, and transcription-coupled repair. In addition, bioenergetic stress potentiates antibiotic persistence via the stringent response. We propose a model in which the balance between ATP consumption versus production regulates antibiotic resistance and persistence.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEnergy MetabolismEscherichia coliStress, PhysiologicalAdenosine TriphosphateDNA RepairMicrobial Sensitivity TestsNADReactive Oxygen SpeciesAdenosine TriphosphateAnti-Bacterial AgentsNADReactive Oxygen Species

Identifiers

PMID40490453
PMCPMC12149317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.